CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Restricted share units	Common Shares	Common Shares Restricted share units	Additional Paid-in Capital	Additional Paid-in Capital Restricted share units	Accumulated Deficit
Balance (in shares) at Dec. 31, 2021			144,659,964
Balance at Dec. 31, 2021	$ 130,446		$ 1		$ 319,059		$ (188,614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Withholding of common shares upon vesting of restricted share units/awards (in shares)			77,193
Common shares issued upon vesting of restricted share units, net of withholding	(45)				(45)
Harmony Hemp contingent equity compensation (in shares)			169,045
Harmony Hemp contingent equity compensation	165				165
ATM program issuance costs (in shares)			239,500
ATM program issuance costs	(2)				(2)
Share-based compensation	1,214				1,214
Net loss	(8,626)						(8,626)
Balance (in shares) at Mar. 31, 2022			145,145,702
Balance at Mar. 31, 2022	123,152		$ 1		320,391		(197,240)
Balance (in shares) at Dec. 31, 2021			144,659,964
Balance at Dec. 31, 2021	130,446		$ 1		319,059		(188,614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(16,496)
Balance (in shares) at Jun. 30, 2022			145,278,165
Balance at Jun. 30, 2022	115,912		$ 1		321,021		(205,110)
Balance (in shares) at Mar. 31, 2022			145,145,702
Balance at Mar. 31, 2022	123,152		$ 1		320,391		(197,240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Withholding of common shares upon vesting of restricted share units/awards (in shares)			132,463
Common shares issued upon vesting of restricted share units, net of withholding	(13)				(13)
Share-based compensation	643				643
Net loss	(7,870)						(7,870)
Balance (in shares) at Jun. 30, 2022			145,278,165
Balance at Jun. 30, 2022	115,912		$ 1		321,021		(205,110)
Balance (in shares) at Dec. 31, 2022			152,135,026
Balance at Dec. 31, 2022	77,505		$ 1		325,431		(247,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Withholding of common shares upon vesting of restricted share units/awards (in shares)				297,888
Common shares issued upon vesting of restricted share units, net of withholding		$ (69)				$ (69)
Share-based compensation	375				375
Net loss	(2,912)						(2,912)
Balance (in shares) at Mar. 31, 2023			152,432,914
Balance at Mar. 31, 2023	74,899		$ 1		325,737		(250,839)
Balance (in shares) at Dec. 31, 2022			152,135,026
Balance at Dec. 31, 2022	77,505		$ 1		325,431		(247,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(67)
Balance (in shares) at Jun. 30, 2023			152,825,118
Balance at Jun. 30, 2023	78,361		$ 1		326,355		(247,995)
Balance (in shares) at Mar. 31, 2023			152,432,914
Balance at Mar. 31, 2023	74,899		$ 1		325,737		(250,839)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Withholding of common shares upon vesting of restricted share units/awards (in shares)				392,204
Common shares issued upon vesting of restricted share units, net of withholding		$ (6)				$ (6)
Share-based compensation	624				624
Net loss	2,844						2,844
Balance (in shares) at Jun. 30, 2023			152,825,118
Balance at Jun. 30, 2023	$ 78,361		$ 1		$ 326,355		$ (247,995)